Bristol Myers Squibb (BMY) Q4 2023 Earnings Report
Bristol-Myers Squibb reported quarterly earnings and revenue on Friday that beat expectations as its portfolio of new drugs posted strong…
Biotechnology
This little-known oncology stock could rise more than 70%, says Citi
Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…
Pfizer (PFE) 2023 Fourth Quarter Earnings Report
Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit as the company's declining Covid business performed better than expected. The…
Merck and J&J CEOs agree to testify at Senate hearing on drug prices
U.S. Senator Bernie Sanders, independent from Vermont, speaks during a People's Action rally, protesting pharmaceutical companies' lobbying against allowing Medicare…
Humana reports grim forecast for 2024 due to rising medical costs
Signs are displayed at a Humana Inc. office building in Louisville, Kentucky, U.S., Sunday, February 3, 2019. Humana is scheduled…
Johnson & Johnson to resolve baby powder investigation
Containers of Johnson and Johnson baby powder are displayed on a shelf at Walgreens on April 5, 2023 in San…
Johnson & Johnson (JNJ) Q4 2023 Earnings
Johnson & Johnson stock chart seen on a smartphone screen. Rafael Enrique | SOPA Images | Light rocket | fake…
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…
Gilead Shares Fall After Disappointing Lung Cancer Study Results
soup images | Light rocket | fake images Actions of Gilead fell more than 9% on Monday after a key…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…